Jack Nathan Medical Corp.
Jack Nathan Medical Corp. (JNHMF) Stock Overview
Explore Jack Nathan Medical Corp.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
301.5K
P/E Ratio
-0.07
EPS (TTM)
$-0.06
ROE
0.81%
JNHMF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Jack Nathan Medical Corp. (JNHMF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.07 and a market capitalization of 301.5K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Jack Nathan Medical Corp., together with its subsidiaries, operates primary care medical clinics in Walmart Supercentres under the Jack Nathan Health brand. As of June 30, 2022, it operated 76 clinics in Walmart locations in Canada, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario,and Quebec, as well as 4 clinics outside Walmart; and 18 medical clinics, 2 Rehab, and 5 MedSpa; and 108 corporate owned and operated clinics in Walmart locations in Mexico. Jack Nathan Medical Corp. was founded in 2006 and is headquartered in Woodbridge, Canada.
Glenn Copeland
6-6150 Highway 7, Woodbridge, ON
2020